The results of our current study indicated that the level of serum S100B protein in patients with SLE was not only significantly higher compared to healthy controls, but also higher compared to SLE stable group and active group, but there was no significant difference between SLE stable group and active group. This evidence concerns the gene S100B and systemic lupus erythematosus.